- BCDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
BioCardia (BCDA) CORRESPCorrespondence with SEC
Filed: 24 Jul 19, 12:00am
July 24, 2019
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Re: BioCardia, Inc.
Registration Statement on Form S-1
File No. 333-230779
VIA EDGAR
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on July 23, 2019, in which we, Maxim Group LLC, as representative of the underwriters of the offering, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, July 25, 2019, at 4:30 p.m., ET, or as soon thereafter as practicable. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
| MAXIM GROUP LLC |
| |
|
|
|
|
|
|
|
|
| By: | /s/ Clifford A. Teller |
|
| Name: Clifford A. Teller Title: Executive Managing Director Head of Investment Banking |
|